ENvue Medical Inc.

FEED | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.03

$0.00 (0.00%)

Nov 2, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Oct 7, 2026

20.8

-8.2 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $951.43K

1D Range

0.84 3.42

52W Range

0.29 5.98

Valuation (TTM)

PE 0

PB 0.03

EV/EBITDA -0.08

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target $4.65

Cash Flow

FCF Yield -1234.3%

SBC Adj. FCF Yield -1234.3%

SBC Impact N/A

Margins

Gross Margin -26.1%

Operating Margin -783.6%

FCF Margin -609.8%

Growth (CAGR)

Revenue 3Y | 5Y 37.3% | 25.8%

Dil EPS 3Y | 5Y -141.2% | -72.5%

FCF 3Y | 5Y -84.6% | -36.5%

Returns

ROA -54.6%

ROE -60.5%

ROIC -45.9%

Financial Health

Net Debt

$101K

Current Ratio 0.66

Interest Coverage -61.10

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span a...

Sector Healthcare

Industry Medical - Specialties

Employees 13

IPO Date Dec 12, 2025

Website envuemed.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.